Multi-component Formulations For The Treatment Of Cognitive Decline Including Alzheimer's Disease


A multi-component formulation for the treatment, delay, and/or prevention of cognitive decline, including Alzheimer's disease, and/or other neurodegenerative diseases. One embodiment of the multi-component formulation comprises methylsulfonylmethane, at least one energy source component, and at least one of an herbal component or a nutritional component. In one formulation, the energy source component is fructose 1,6-disphosphate. An herbal component of at least one formulation is curcumin. In one further formulation, a nutritional component is selected from the group consisting of docosahexaenoic acid, resveratrol, and blueberry.

Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jun 20, 2017
  • Application: Jun 7, 2013
    US US 201313912844 A
  • Priority: Jun 7, 2013
    US US 201313912844 A
  • Priority: Mar 18, 2013
    US US 201361852511 P
  • Priority: Oct 12, 2011
    US US 201113271266 A
  • Priority: Oct 12, 2010
    US US 40476910 P

Sign in to the Lens